Medlive Technology Co (HKSE:02192) FCF Margin % : 19.02% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medlive Technology Co's Free Cash Flow for the six months ended in Dec. 2023 was HK$49.6 Mil. Medlive Technology Co's Revenue for the six months ended in Dec. 2023 was HK$260.9 Mil. Therefore, Medlive Technology Co's FCF Margin % for the quarter that ended in Dec. 2023 was 19.02%.

As of today, Medlive Technology Co's current FCF Yield % is 1.25%.

The historical rank and industry rank for Medlive Technology Co's FCF Margin % or its related term are showing as below:

HKSE:02192' s FCF Margin % Range Over the Past 10 Years
Min: 14.93 Med: 21.7 Max: 51.71
Current: 16.83

During the past 6 years, the highest FCF Margin % of Medlive Technology Co was 51.71%. The lowest was 14.93%. And the median was 21.70%.

HKSE:02192's FCF Margin % is ranked better than
95.88% of 97 companies
in the Medical Distribution industry
Industry Median: 0.95 vs HKSE:02192: 16.83

Medlive Technology Co FCF Margin % Historical Data

The historical data trend for Medlive Technology Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co FCF Margin % Chart

Medlive Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

21.20

51.71

14.93

22.19

16.83

Medlive Technology Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial					4.30	18.95	24.54	13.82	19.02

Competitive Comparison of Medlive Technology Co's FCF Margin %

For the Medical Distribution subindustry, Medlive Technology Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlive Technology Co's FCF Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's FCF Margin % falls into.

Medlive Technology Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medlive Technology Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	75.843	/	450.641
	=	16.83 %

Medlive Technology Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	49.614	/	260.864
	=	19.02 %

Medlive Technology Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co (HKSE:02192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines